FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OLYMPIA PHARMACY | 017674368 | .alpha.-Lipoic Acid | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Epinephrine; Lidocaine Hydrochloride | .01 mg/1 mL; .01 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Acetylcysteine | 200 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Alprostadil | .08 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Alprostadil | .15 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glutamine | 30 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glutamine; Ornithine; Lysine Hydrochloride; Arginine; Citrulline; Levocarnitine | 30 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 100 mg/1 mL; 50 mg/1 mL; 100 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glutathione | 200 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glutathione | 200 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glutathione; Ascorbic Acid; Zinc Sulfate | 200 mg/1 mL; 200 mg/1 mL; 2.5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glycerin | .72 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Glycerin; Epinephrine; Lidocaine Hydrochloride | 480 mg/1 mL; .00333 mg/1 mL; 3.33 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Hydroxocobalamin | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Hydroxocobalamin; Folic Acid | 1 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Hydroxocobalamin; Levocarnitine; Succinylcholine Chloride; Methionine; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 1 mg/1 mL; 125 mg/1 mL; 25 mg/1 mL; 12.4 mg/1 mL; 5 mg/1 mL; 50 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Hydroxocobalamin; Pyridoxine; Succinylcholine Chloride; Methionine; Inositol | 1 mg/1 mL; .175 mg/1 mL; 50 mg/1 mL; 25 mg/1 mL; 50 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Arginine | 200 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Levocarnitine | 500 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 125 mg/1 mL; 2 mg/1 mL; 25 mg/1 mL; 12.4 mg/1 mL; 25 mg/1 mL; 5 mg/1 mL; 50 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Cyanocobalamin | 125 mg/1 mL; 2 mg/1 mL; 25 mg/1 mL; 12.4 mg/1 mL; 25 mg/1 mL; 5 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride; Cyanocobalamin | 125 mg/1 mL; 2 mg/1 mL; 25 mg/1 mL; 12.4 mg/1 mL; 25 mg/1 mL; 5 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine | .01 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine | .02 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| OurPharma LLC | 041422637 | 73013-1001 | 73013-1001-1 | Fentanyl Citrate | 50 ug/1 mL | 2021-1 | valid | 2026-11-12 | |
| OurPharma LLC | 041422637 | 73013-1004 | 73013-1004-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2 ug/1 mL; 1.25 mg/1 mL | 2021-1 | valid | 2026-11-12 | |
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1.5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Pilocarpine Hydrochloride | 4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Potassium Palmitate | 620 ug/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride; Gentamicin Sulfate | 1 mg/.12 mL; 4 mg/.12 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Chloride | 20 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 |